CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...
People everywhere are using AI to get creative, spend more time with loved ones and ditch mundane tasks — all things they wouldn’t have even imagined a year ago, before generative AI became widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results